Lavipharm S.A. (ATH:LAVI)
Greece flag Greece · Delayed Price · Currency is EUR
1.540
-0.006 (-0.39%)
Jun 11, 2026, 3:24 PM EET

Lavipharm Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2641641341346430
Market Cap Growth
97.37%22.01%0.36%107.29%117.58%23.40%
Enterprise Value
2911911571619866
Last Close Price
1.550.970.780.780.371.58
PE Ratio
51.7827.3414.9371.4277.2917.20
PS Ratio
4.092.622.532.791.650.75
PB Ratio
4.682.902.533.121.60-2.98
P/TBV Ratio
18.1011.2217.2178.88--
P/FCF Ratio
-30.35---13.52
P/OCF Ratio
-24.5629.82470.5119.277.21
EV/Sales Ratio
4.503.062.963.362.501.67
EV/EBITDA Ratio
20.6214.8117.6919.4419.7012.35
EV/EBIT Ratio
32.6822.1831.1734.1124.0114.66
EV/FCF Ratio
-35.47---30.17
Debt / Equity Ratio
0.580.580.640.760.92-3.76
Debt / EBITDA Ratio
2.322.393.533.646.686.28
Debt / FCF Ratio
-6.08---17.03
Net Debt / Equity Ratio
0.470.470.540.560.47-3.59
Net Debt / EBITDA Ratio
2.012.073.202.913.826.66
Net Debt / FCF Ratio
-4.95-5.51-6.39-0.5916.28
Asset Turnover
-0.490.440.420.470.77
Inventory Turnover
-1.491.521.932.182.70
Quick Ratio
-0.650.560.660.700.35
Current Ratio
-1.211.151.271.000.63
Return on Equity (ROE)
-9.23%18.10%4.74%6.25%-
Return on Assets (ROA)
-4.22%2.62%2.57%3.04%5.46%
Return on Invested Capital (ROIC)
7.10%7.06%6.79%4.58%4.02%11.00%
Return on Capital Employed (ROCE)
-10.00%5.80%6.00%5.90%38.60%
Earnings Yield
1.96%3.66%6.70%1.40%1.29%5.82%
FCF Yield
-3.29%-3.84%-2.82%-50.06%7.40%
Dividend Yield
1.28%-2.58%---
Payout Ratio
-56.48%----
Buyback Yield / Dilution
-0.06%-0.17%-681.40%-26.42%-
Total Shareholder Return
1.28%0.06%2.40%-681.40%-26.42%-